Anti-Kairi Virus (KRIV) Nucleocapsid ant - 0.2mg/mL
Ref. 3D-CRB2005080
20µg | 266,00 € | ||
100µg | 479,00 € |
Produktinformation
KRIV belongs to the Peribunyaviridae family of viruses (previously called Bunyaviridae). KRIV was first isolated from mosquito species in Trinidad including Aedes, Wyeomia, Culex and Psorophora spp. and has since been isolated from mosquitoes and vertebrates in Central and South America. Although between 6-18% of humans and up to 48% of horses have antibodies to KRIV, it does not cause any documented clinical disease symptoms in humans or animals. KRVI consists of three genome segments (called L [large], M [medium] and S [small]) which are encapsidated by the nucleocapsid (N) protein. These segments associate with the viral RNA-dependent RNA polymerase, the L protein, to form ribonucleoprotein complexes (RNP) termed nucleocapsids. RNPs are contained within a lipid envelope also containing the viral glycoproteins, Gn and Gc.
1mg/ml. For use in WB and ELISA. Reacts with Kairi Virus.
Image: Western blot analysis of BHK-21 cells infected with the Kairi virus.
Chemische Eigenschaften
Technische Anfrage zu: 3D-CRB2005080 Anti-Kairi Virus (KRIV) Nucleocapsid ant - 0.2mg/mL
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.